ID   PDE8A_HUMAN             Reviewed;         829 AA.
AC   O60658; B3KXE6; H0YMZ7; Q6P9H3; Q969I1; Q96PC9; Q96PD0; Q96PD1;
AC   Q96T71; Q9UMB7; Q9UMC3;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2002, sequence version 2.
DT   15-MAR-2017, entry version 177.
DE   RecName: Full=High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A;
DE            EC=3.1.4.53 {ECO:0000250|UniProtKB:O95263};
GN   Name=PDE8A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5).
RC   TISSUE=Testis;
RX   PubMed=11738832; DOI=10.1016/S0378-1119(01)00783-1;
RA   Wang P., Wu P., Egan R.W., Billah M.M.;
RT   "Human phosphodiesterase 8A splice variants: cloning, gene
RT   organization, and tissue distribution.";
RL   Gene 280:183-194(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11371644; DOI=10.1073/pnas.101131098;
RA   Glavas N.A., Ostenson C., Schaefer J.B., Vasta V., Beavo J.A.;
RT   "T cell activation up-regulates cyclic nucleotide phosphodiesterases
RT   8A1 and 7A3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:6319-6324(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 381-829 (ISOFORM 1), AND VARIANT
RP   GLY-112.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLY-112.
RC   TISSUE=Liver, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 117-829 (ISOFORMS 1 AND 2).
RX   PubMed=9618252; DOI=10.1006/bbrc.1998.8684;
RA   Fisher D.A., Smith J.F., Pillar J.S., St Denis S.H., Cheng J.B.;
RT   "Isolation and characterization of PDE8A, a novel human cAMP-specific
RT   phosphodiesterase.";
RL   Biochem. Biophys. Res. Commun. 246:570-577(1998).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 554-829.
RG   The European IMAGE consortium;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20 AND SER-457, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION AT SER-359.
RX   PubMed=22673573; DOI=10.1016/j.febslet.2012.04.033;
RA   Brown K.M., Lee L.C., Findlay J.E., Day J.P., Baillie G.S.;
RT   "Cyclic AMP-specific phosphodiesterase, PDE8A1, is activated by
RT   protein kinase A-mediated phosphorylation.";
RL   FEBS Lett. 586:1631-1637(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20 AND SER-457, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   FUNCTION, INTERACTION WITH RAF1, MUTAGENESIS OF 454-ARG-ARG-455 AND
RP   460-GLU-LYS-461, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23509299; DOI=10.1073/pnas.1303004110;
RA   Brown K.M., Day J.P., Huston E., Zimmermann B., Hampel K.,
RA   Christian F., Romano D., Terhzaz S., Lee L.C., Willis M.J.,
RA   Morton D.B., Beavo J.A., Shimizu-Albergine M., Davies S.A., Kolch W.,
RA   Houslay M.D., Baillie G.S.;
RT   "Phosphodiesterase-8A binds to and regulates Raf-1 kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:E1533-E1542(2013).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 482-819 IN COMPLEX WITH
RP   METAL IONS AND THE INHIBITOR IBMX, FUNCTION, COFACTOR, AND MUTAGENESIS
RP   OF TYR-748.
RX   PubMed=18983167; DOI=10.1021/bi801487x;
RA   Wang H., Yan Z., Yang S., Cai J., Robinson H., Ke H.;
RT   "Kinetic and structural studies of phosphodiesterase-8A and
RT   implication on the inhibitor selectivity.";
RL   Biochemistry 47:12760-12768(2008).
CC   -!- FUNCTION: Hydrolyzes the second messenger cAMP, which is a key
CC       regulator of many important physiological processes
CC       (PubMed:18983167). May be involved in maintaining basal levels of
CC       the cyclic nucleotide and/or in the cAMP regulation of germ cell
CC       development (PubMed:18983167). Binding to RAF1 reduces RAF1 'Ser-
CC       259' inhibitory-phosphorylation and stimulates RAF1-dependent EGF-
CC       activated ERK-signaling (PubMed:23509299). Protects against cell
CC       death induced by hydrogen peroxide and staurosporine
CC       (PubMed:23509299). {ECO:0000269|PubMed:18983167,
CC       ECO:0000269|PubMed:23509299}.
CC   -!- CATALYTIC ACTIVITY: Adenosine 3',5'-cyclic phosphate + H(2)O =
CC       adenosine 5'-phosphate. {ECO:0000250|UniProtKB:O95263}.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000269|PubMed:18983167};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions. {ECO:0000269|PubMed:18983167};
CC   -!- ENZYME REGULATION: Inhibited by dipyridimole. Insensitive to
CC       selective PDE inhibitors including rolipram and zaprinast as well
CC       as to the non-selective inhibitor, IBMX. Unaffected by cGMP.
CC       {ECO:0000250|UniProtKB:O95263}.
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic AMP degradation; AMP from
CC       3',5'-cyclic AMP: step 1/1.
CC   -!- SUBUNIT: Interacts with RAF1. The interaction promotes RAF1
CC       activity. {ECO:0000269|PubMed:23509299}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=PDE8A1;
CC         IsoId=O60658-1; Sequence=Displayed;
CC       Name=2; Synonyms=PDE8A2;
CC         IsoId=O60658-2; Sequence=VSP_004597;
CC       Name=3; Synonyms=PDE8A3;
CC         IsoId=O60658-3; Sequence=VSP_041675, VSP_041677;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay. No
CC         experimental confirmation available.;
CC       Name=4; Synonyms=PDE8A4;
CC         IsoId=O60658-4; Sequence=VSP_041674, VSP_041676;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay. No
CC         experimental confirmation available.;
CC       Name=5; Synonyms=PDE8A5;
CC         IsoId=O60658-5; Sequence=VSP_041678, VSP_041679;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay. No
CC         experimental confirmation available.;
CC       Name=6;
CC         IsoId=O60658-6; Sequence=VSP_046017;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues except thymus and
CC       peripheral blood leukocytes. Highest levels in testis, ovary,
CC       small intestine and colon.
CC   -!- DOMAIN: Composed of a C-terminal catalytic domain containing two
CC       putative divalent metal sites and an N-terminal regulatory domain.
CC   -!- PTM: Phosphorylated at Ser-359 by PKA under elevated cAMP
CC       conditions, this enhances catalytic activity.
CC       {ECO:0000269|PubMed:22673573}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. PDE8 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL18612.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC       Sequence=AAL18613.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC       Sequence=AAL18614.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC       Sequence=BAG54458.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=EAX01967.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF388183; AAL18610.1; -; mRNA.
DR   EMBL; AF388184; AAL18611.1; -; mRNA.
DR   EMBL; AF388185; AAL18612.1; ALT_SEQ; mRNA.
DR   EMBL; AF388186; AAL18613.1; ALT_SEQ; mRNA.
DR   EMBL; AF388187; AAL18614.1; ALT_SEQ; mRNA.
DR   EMBL; AF332653; AAK57641.1; -; mRNA.
DR   EMBL; AK074280; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK127232; BAG54458.1; ALT_SEQ; mRNA.
DR   EMBL; AC027078; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471101; EAX01967.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC060762; AAH60762.1; -; mRNA.
DR   EMBL; BC075822; AAH75822.1; -; mRNA.
DR   EMBL; AF056490; AAC39763.1; -; mRNA.
DR   EMBL; AL109687; CAB52020.1; -; mRNA.
DR   EMBL; AL109778; CAB52432.1; -; mRNA.
DR   CCDS; CCDS10336.1; -. [O60658-1]
DR   CCDS; CCDS10337.1; -. [O60658-2]
DR   CCDS; CCDS58397.1; -. [O60658-6]
DR   PIR; JW0088; JW0088.
DR   RefSeq; NP_001230066.1; NM_001243137.1. [O60658-6]
DR   RefSeq; NP_002596.1; NM_002605.2. [O60658-1]
DR   RefSeq; NP_775656.1; NM_173454.1. [O60658-2]
DR   RefSeq; XP_016877800.1; XM_017022311.1.
DR   UniGene; Hs.9333; -.
DR   PDB; 1LHQ; Model; -; A=482-821.
DR   PDB; 1LXX; Model; -; A=488-821.
DR   PDB; 3ECM; X-ray; 1.90 A; A=482-819.
DR   PDB; 3ECN; X-ray; 2.10 A; A/B=482-819.
DR   PDBsum; 1LHQ; -.
DR   PDBsum; 1LXX; -.
DR   PDBsum; 3ECM; -.
DR   PDBsum; 3ECN; -.
DR   ProteinModelPortal; O60658; -.
DR   SMR; O60658; -.
DR   BioGrid; 111177; 2.
DR   IntAct; O60658; 2.
DR   STRING; 9606.ENSP00000311453; -.
DR   BindingDB; O60658; -.
DR   ChEMBL; CHEMBL4640; -.
DR   DrugBank; DB07954; 3-isobutyl-1-methyl-7H-xanthine.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB00920; Ketotifen.
DR   GuidetoPHARMACOLOGY; 1307; -.
DR   iPTMnet; O60658; -.
DR   PhosphoSitePlus; O60658; -.
DR   BioMuta; PDE8A; -.
DR   MaxQB; O60658; -.
DR   PaxDb; O60658; -.
DR   PeptideAtlas; O60658; -.
DR   PRIDE; O60658; -.
DR   Ensembl; ENST00000310298; ENSP00000311453; ENSG00000073417. [O60658-1]
DR   Ensembl; ENST00000339708; ENSP00000340679; ENSG00000073417. [O60658-2]
DR   Ensembl; ENST00000394553; ENSP00000378056; ENSG00000073417. [O60658-1]
DR   Ensembl; ENST00000478717; ENSP00000432309; ENSG00000073417. [O60658-4]
DR   Ensembl; ENST00000557957; ENSP00000453808; ENSG00000073417. [O60658-6]
DR   GeneID; 5151; -.
DR   KEGG; hsa:5151; -.
DR   UCSC; uc002blh.4; human. [O60658-1]
DR   CTD; 5151; -.
DR   DisGeNET; 5151; -.
DR   GeneCards; PDE8A; -.
DR   H-InvDB; HIX0012539; -.
DR   HGNC; HGNC:8793; PDE8A.
DR   HPA; HPA007722; -.
DR   MIM; 602972; gene.
DR   neXtProt; NX_O60658; -.
DR   OpenTargets; ENSG00000073417; -.
DR   PharmGKB; PA33141; -.
DR   eggNOG; KOG1229; Eukaryota.
DR   eggNOG; ENOG410XP9B; LUCA.
DR   GeneTree; ENSGT00760000118889; -.
DR   HOVERGEN; HBG053544; -.
DR   KO; K18437; -.
DR   OMA; KIGKEWQ; -.
DR   OrthoDB; EOG091G0337; -.
DR   PhylomeDB; O60658; -.
DR   TreeFam; TF314638; -.
DR   BRENDA; 3.1.4.53; 2681.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   UniPathway; UPA00762; UER00747.
DR   ChiTaRS; PDE8A; human.
DR   EvolutionaryTrace; O60658; -.
DR   GeneWiki; PDE8A; -.
DR   GenomeRNAi; 5151; -.
DR   PRO; PR:O60658; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000073417; -.
DR   CleanEx; HS_PDE8A; -.
DR   ExpressionAtlas; O60658; baseline and differential.
DR   Genevisible; O60658; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; TAS:Reactome.
DR   GO; GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; NAS:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006198; P:cAMP catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IMP:UniProtKB.
DR   GO; GO:0009187; P:cyclic nucleotide metabolic process; NAS:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; IMP:UniProtKB.
DR   GO; GO:1903206; P:negative regulation of hydrogen peroxide-induced cell death; IMP:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR013767; PAS_fold.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   Pfam; PF00989; PAS; 1.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50112; PAS; 1.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; cAMP; Complete proteome;
KW   Hydrolase; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    829       High affinity cAMP-specific and IBMX-
FT                                insensitive 3',5'-cyclic
FT                                phosphodiesterase 8A.
FT                                /FTId=PRO_0000198838.
FT   DOMAIN      213    283       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN      287    329       PAC.
FT   REGION      454    461       Involved in RAF1-binding.
FT                                {ECO:0000269|PubMed:23509299}.
FT   REGION      531    813       Catalytic. {ECO:0000250}.
FT   ACT_SITE    556    556       Proton donor.
FT                                {ECO:0000250|UniProtKB:O76083}.
FT   METAL       560    560       Divalent metal cation 1; via tele
FT                                nitrogen. {ECO:0000244|PDB:3ECM,
FT                                ECO:0000269|PubMed:18983167,
FT                                ECO:0000312|PDB:3ECN}.
FT   METAL       596    596       Divalent metal cation 1; via tele
FT                                nitrogen. {ECO:0000244|PDB:3ECM,
FT                                ECO:0000269|PubMed:18983167,
FT                                ECO:0000312|PDB:3ECN}.
FT   METAL       597    597       Divalent metal cation 1.
FT                                {ECO:0000244|PDB:3ECM,
FT                                ECO:0000269|PubMed:18983167,
FT                                ECO:0000312|PDB:3ECN}.
FT   METAL       597    597       Divalent metal cation 2.
FT                                {ECO:0000244|PDB:3ECM,
FT                                ECO:0000269|PubMed:18983167,
FT                                ECO:0000312|PDB:3ECN}.
FT   METAL       726    726       Divalent metal cation 1.
FT                                {ECO:0000244|PDB:3ECM,
FT                                ECO:0000269|PubMed:18983167,
FT                                ECO:0000312|PDB:3ECN}.
FT   MOD_RES      20     20       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     359    359       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:22673573}.
FT   MOD_RES     386    386       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88502}.
FT   MOD_RES     457    457       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     461    461       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O88502}.
FT   VAR_SEQ       1     72       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046017.
FT   VAR_SEQ     212    228       RACNSVFTALENSEDAI -> SMQILHLKQQWAISQVN
FT                                (in isoform 4).
FT                                {ECO:0000303|PubMed:11738832}.
FT                                /FTId=VSP_041674.
FT   VAR_SEQ     213    231       ACNSVFTALENSEDAIEIT -> SGKEFTMQKRKTEIIYNK
FT                                M (in isoform 3).
FT                                {ECO:0000303|PubMed:11738832}.
FT                                /FTId=VSP_041675.
FT   VAR_SEQ     229    829       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11738832}.
FT                                /FTId=VSP_041676.
FT   VAR_SEQ     232    829       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11738832}.
FT                                /FTId=VSP_041677.
FT   VAR_SEQ     239    284       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11738832,
FT                                ECO:0000303|PubMed:9618252}.
FT                                /FTId=VSP_004597.
FT   VAR_SEQ     239    272       YANPAFETTMGYQSGELIGKELGEVPINEKKADL -> PCC
FT                                SSSWFGAAHIPSSAPVEVGVGLLPSWSLRRT (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:11738832}.
FT                                /FTId=VSP_041678.
FT   VAR_SEQ     273    829       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:11738832}.
FT                                /FTId=VSP_041679.
FT   VARIANT     112    112       E -> G (in dbSNP:rs17855018).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_069109.
FT   MUTAGEN     454    455       RR->AA: Reduces interaction with RAF1;
FT                                when associated with A-460 and A-461.
FT                                {ECO:0000269|PubMed:23509299}.
FT   MUTAGEN     460    461       EY->AA: Reduces interaction with RAF1;
FT                                when associated with A-454 and A-455.
FT                                {ECO:0000269|PubMed:23509299}.
FT   MUTAGEN     748    748       Y->F: Increases sensitivity to several
FT                                nonselective or family selective PDE
FT                                inhibitors.
FT                                {ECO:0000269|PubMed:18983167}.
FT   CONFLICT     55     55       L -> V (in Ref. 2; AAK57641).
FT                                {ECO:0000305}.
FT   CONFLICT    344    344       H -> R (in Ref. 2; AAK57641 and 7;
FT                                AAC39763). {ECO:0000305}.
FT   CONFLICT    399    399       I -> V (in Ref. 2; AAK57641 and 7;
FT                                AAC39763). {ECO:0000305}.
FT   HELIX       486    491       {ECO:0000244|PDB:3ECM}.
FT   TURN        492    496       {ECO:0000244|PDB:3ECM}.
FT   STRAND      497    499       {ECO:0000244|PDB:3ECM}.
FT   HELIX       502    508       {ECO:0000244|PDB:3ECM}.
FT   HELIX       513    524       {ECO:0000244|PDB:3ECM}.
FT   HELIX       528    531       {ECO:0000244|PDB:3ECM}.
FT   HELIX       535    547       {ECO:0000244|PDB:3ECM}.
FT   STRAND      553    557       {ECO:0000244|PDB:3ECM}.
FT   HELIX       558    572       {ECO:0000244|PDB:3ECM}.
FT   HELIX       575    578       {ECO:0000244|PDB:3ECM}.
FT   HELIX       583    595       {ECO:0000244|PDB:3ECM}.
FT   TURN        596    599       {ECO:0000244|PDB:3ECM}.
FT   HELIX       605    610       {ECO:0000244|PDB:3ECM}.
FT   HELIX       614    618       {ECO:0000244|PDB:3ECM}.
FT   TURN        619    621       {ECO:0000244|PDB:3ECM}.
FT   HELIX       624    638       {ECO:0000244|PDB:3ECM}.
FT   TURN        641    643       {ECO:0000244|PDB:3ECM}.
FT   TURN        645    648       {ECO:0000244|PDB:3ECM}.
FT   HELIX       651    666       {ECO:0000244|PDB:3ECM}.
FT   HELIX       670    672       {ECO:0000244|PDB:3ECM}.
FT   HELIX       673    683       {ECO:0000244|PDB:3ECM}.
FT   HELIX       685    691       {ECO:0000244|PDB:3ECM}.
FT   HELIX       692    694       {ECO:0000244|PDB:3ECN}.
FT   HELIX       698    708       {ECO:0000244|PDB:3ECM}.
FT   HELIX       711    726       {ECO:0000244|PDB:3ECM}.
FT   HELIX       729    731       {ECO:0000244|PDB:3ECM}.
FT   HELIX       734    758       {ECO:0000244|PDB:3ECM}.
FT   TURN        769    771       {ECO:0000244|PDB:3ECM}.
FT   HELIX       774    784       {ECO:0000244|PDB:3ECM}.
FT   HELIX       786    797       {ECO:0000244|PDB:3ECM}.
FT   HELIX       800    814       {ECO:0000244|PDB:3ECM}.
SQ   SEQUENCE   829 AA;  93304 MW;  99BD05EA185A42CD CRC64;
     MGCAPSIHIS ERLVAEDAPS PAAPPLSSGG PRLPQGQKTA ALPRTRGAGL LESELRDGSG
     KKVAVADVQF GPMRFHQDQL QVLLVFTKED NQCNGFCRAC EKAGFKCTVT KEAQAVLACF
     LDKHHDIIII DHRNPRQLDA EALCRSIRSS KLSENTVIVG VVRRVDREEL SVMPFISAGF
     TRRYVENPNI MACYNELLQL EFGEVRSQLK LRACNSVFTA LENSEDAIEI TSEDRFIQYA
     NPAFETTMGY QSGELIGKEL GEVPINEKKA DLLDTINSCI RIGKEWQGIY YAKKKNGDNI
     QQNVKIIPVI GQGGKIRHYV SIIRVCNGNN KAEKISECVQ SDTHTDNQTG KHKDRRKGSL
     DVKAVASRAT EVSSQRRHSS MARIHSMTIE APITKVINII NAAQESSPMP VTEALDRVLE
     ILRTTELYSP QFGAKDDDPH ANDLVGGLMS DGLRRLSGNE YVLSTKNTQM VSSNIITPIS
     LDDVPPRIAR AMENEEYWDF DIFELEAATH NRPLIYLGLK MFARFGICEF LHCSESTLRS
     WLQIIEANYH SSNPYHNSTH SADVLHATAY FLSKERIKET LDPIDEVAAL IAATIHDVDH
     PGRTNSFLCN AGSELAILYN DTAVLESHHA ALAFQLTTGD DKCNIFKNME RNDYRTLRQG
     IIDMVLATEM TKHFEHVNKF VNSINKPLAT LEENGETDKN QEVINTMLRT PENRTLIKRM
     LIKCADVSNP CRPLQYCIEW AARISEEYFS QTDEEKQQGL PVVMPVFDRN TCSIPKSQIS
     FIDYFITDMF DAWDAFVDLP DLMQHLDNNF KYWKGLDEMK LRNLRPPPE
//
